Green Cross Corp EP4242224A1 Coronavirus Spike Protein Antibody Patent
Summary
Green Cross Corporation and Mogam Institute for Biomedical Research have obtained EPO publication EP4242224A1 for an antibody specific to coronavirus spike protein, classified under IPC C07K 16/10 and A61P 31/14. The patent names 13 inventors: Dong-Sik Kim, Sua Lee, Shin A Jang, Jihoon Kang, Ki Joon Cho, Soo Bin Park, Young Woo Han, Hyemi Nam, Mi Young Oh, Jee Boong Lee, Jihye Ryu, Mun Kyung Kim, and Jeewon Lee. The designated states cover 35 European contracting states including Germany, France, United Kingdom, Italy, Spain, Netherlands, Belgium, and other EU/EEA jurisdictions.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The EPO has published patent application EP4242224A1 for an antibody targeting coronavirus spike protein, filed by Green Cross Corporation and Mogam Institute for Biomedical Research. The application is classified under C07K 16/10 (immunoglobulins) and A61P 31/14 (antivirals for RNA viruses), with designations covering 35 European contracting states.
Pharmaceutical companies and biotech firms developing coronavirus therapeutics or diagnostics should review this patent for potential freedom-to-operate concerns or licensing opportunities. The designated state coverage (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR) indicates broad European market protection.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTIBODY SPECIFIC TO CORONAVIRUS SPIKE PROTEIN AND USE THEREOF
Publication EP4242224A1 Kind: A1 Apr 15, 2026
Applicants
Green Cross Corporation, Mogam Institute for Biomedical Research
Inventors
KIM, Dong-Sik, LEE, Sua, JANG, Shin A, KANG, Jihoon, CHO, KI Joon, PARK, Soo Bin, HAN, Young Woo, NAM, Hyemi, OH, Mi Young, LEE, Jee Boong, RYU, Jihye, KIM, Mun Kyung, LEE, Jeewon
IPC Classifications
C07K 16/10 20060101AFI20250116BHEP A61P 31/14 20060101ALI20250116BHEP A61K 39/395 20060101ALI20250116BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.